A new study published in the journal of Arthritis Care and Research revelaed that metabolic syndrome is associated with ...

Incidences of malignant neoplasms were low and stable with long-term ixekizumab treatment for people with psoriatic disease ...

Significant gaps in arthritis subtype awareness among US adults underscore the need for improved health literacy and more ...

Some treatments for rheumatoid arthritis could increase cancer risk. One reason is because some cells in our immune system ...

Michaela Hagenhofer, General Manager, Commercial Operations at Johnson & Johnson Innovative Medicine, explains how J&J is ...

Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of ...

Lupin and Zentiva partner to commercialize Certolizumab Pegol biosimilar globally, sharing profits and investing in ...

This review discusses the features of oligoarticular, polyarticular, systemic, and psoriatic JIA and enthesitis-related ...

When psoriatic arthritis symptoms are under control, you may be tempted to stop taking medication. Here’s why that’s a bad idea.

Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...